Inotropic Agents

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/66

encourage image

There's no tags or description

Looks like no tags are added yet.

67 Terms

1
New cards

____ acts on contractility

inotropes

2
New cards

rate of heart contraction (HR)

chronotrophy

3
New cards

conduction velocity of of electrical signals in the heart

dromotrophy

4
New cards

how quickly heart relaxes and recover during diastole

lusitropy

5
New cards

Cardiac output (CO)=

cardiac rate x stroke volume

6
New cards

how much blood is coming back to heart (fluid volume aka the amount of blood returning via venous return) and is heavily influenced by renal excretion and diuretics

preload

7
New cards

what happens in vessels → TPR (total peripheral resistance) is determined by vascular tone

  • more vasoconstriction = 👆 TPR = more hard for heart to pump blood out


afterload

8
New cards

Pathway of NE to increase heart contractility via cAMP:

  1. NE binds to B1 adrenergic receptors (Gs-coupled)

  2. activation of Gs protein stimulates adenylate cyclase

  3. adenylate cyclase convert ATP to cAMP → raises intracellular cAMP levels

  4. high cAMP levels activates Protein Kinase A → allows extracellular calcium to enter cardiomyocytes AND phosphorylates calcium in sarcoplasmic reticulum (this triggers release of steroid calcium from SR into cytoplasm)

  5. influx and release of calcium causes calcium to bind to troponin C → shifts tropomyosin out of the way, allowing actin and myosin to bind

  6. formation of actin-myosin crossbridges drives the sliding of muscle filaments, resulting in strong force of contraction (positive inotrophy)


PDE3: enzyme found in caardiomyocytes that is responsible for the breakdown of cAMP

  • inhibition of PDE3 leads to ______


increase cAMP which increase force of contraction

9
New cards

____ inotropes will INCREASE myocardial contractility

positive

10
New cards

MOA of inotropic agents

Key mechanisms include:

  • ↑ intracellular calcium availability in cardiac myocytes.

  • ↑ sympathetic nervous system stimulation.

  • Modulating cyclic AMP pathways.

Impact on cardiac output and workload: improved stroke volume but ↑ myocardial oxygen consumption.

  • this means ____


this is a problem in pt with CAD

11
New cards

list the catecholamine drugs

dobutamine, dopamine, epinephrine, norepinephrine, isoproterenol

12
New cards

MOA of catecholamines

B-1 receptor agonists

13
New cards

what is the effect of catecholamines

Increased cAMP

14
New cards

list the PDE3i

milrinone

15
New cards

PDE3i are also known as

inodilators

16
New cards

MOA of PDE3i

prevents cAMP breakdown

17
New cards

effects of PDEi

increase cAMP levels independent of B-1 receptor activation, leading to increased myocardial contractility and vasodilation.

18
New cards

PDE3i is used for

decompensated heart failure

19
New cards

dobutamine is a catecholamine, its MOA is

selective B1 agonist

20
New cards

dobutamine is used for

cardiogenic shock and HF with decreased output

21
New cards

dopamine is dose dependent

low= dopaminergic receptors
medium= B1
high= A1

22
New cards

epinephrine MOA

combined beta and alpha agonist

23
New cards

epinephrine effects

increase cardiac output and BP

24
New cards

isoproterenol MOA

nonselective B1/B2 agonist

25
New cards

isoproterenol effects

increases heart rate and decreases SVR

26
New cards

list the cardiac glycosides

digoxin

27
New cards

digoxin MOA

inhibits Na+/K+ ATPase

28
New cards

digoxin effects

increasing intracellular calcium

29
New cards

list which categories are cAMP dependent

catecholamines and PDE3i

30
New cards

list cAMP dependent drugs

digoxin

31
New cards

CI for dobutamine

tachyarrhymias, ischemic hypotension, effects are blunted on B-blockers, tolerance by 72 hours

32
New cards

dopamine effects

DA= renal vasodilation, B1= ino/chronotropy, A1= vasoconstriction

33
New cards

dopamine ADR

arrhythmias, extravasation

34
New cards

epinephrine use

refractoru shock, cardiac arrest, anaphylaxis

35
New cards

CI for epinephrine

increase lactate, increased glucose, arrhythmias

36
New cards

use of isoproterenol:

bradyarrhythmias, torsades bridging

37
New cards

isoproterenol CI

hypotension, tachycardias, ischemias

38
New cards

norephinephrine MOA

stimulates A1 > B1

39
New cards

NE effects

increased SVR and BP

40
New cards

NE use

vasopressor in septic and cardiogenic shock

41
New cards

NE ADRs

reflex bradycardias, extravasation

42
New cards

milirinone MOA

PDE3i

43
New cards

milrinone effects

increase cAMP in myocardium and vessels leading to positive inotropy, lusitropy and vasodilation.

44
New cards

renal fact about milrinone

decrease dose in renal impairment

45
New cards

milrinone use

right ventricular failure and pulmonary HTN

46
New cards

milrinone ADR

hypotension due to vasodilation, arrhythmias, thrombocytopenias

47
New cards

digoxin effects

mild inotrophy and vagal AV nodal slowing

48
New cards

digoxin MOA with antiport

  • digoxin binds to Na+/K+ pump in same place where K+ binds → inhibits

  • _____ is an antiport that uses high Na+ concentration created by the Na+/K+ pump to pump out calcium

    • therefore, decreased Na+ concentration makes this exchanger less effective = Ca2+ is stuck in cell → leads to more contractions


Na+/Ca2+

49
New cards

digoxin elimination

renal

50
New cards

digitoxin metabolism

hepatic (Liver)

51
New cards

digoxin electrolytes interactions:

  • with HYPERkalemia


decrease digoxin binding to Na+/K+ pump, reducing effectiveness

52
New cards

digoxin electrolytes interactions:

  • with HYPOkalemia


increase digoxin binding to Na+/K+ pump, increasing toxicity

53
New cards

digoxin electrolytes interactions:

  • HYPERcalcemia


arrhythmias and increased toxicity

54
New cards

digoxin electrolytes interactions:

  • HYPOmagenesia


arrhythmias and increased toxicity

55
New cards

digoxin ADRs

visual halos/yellow green vision, bradyarrhythmias (most dangerous is 2° AV block)

56
New cards

digoxin antidote

digibind

57
New cards

digibind elimination

renal

58
New cards

digibind ADR

hypersensitivity

59
New cards

digibind CI

sheep sensitivity, papin, papaya extract

60
New cards

digoxin is pumped out by ____

pgp

61
New cards

digoxin DDIs:

  • these drugs blocks pgp, INCREASING digoxin levels


amiodarone, dronedarone, verapamil, quinidine, azole antifungals and macrolides (erythromycin, fluconazole, spironolactone)

62
New cards

which digoxin DDI is potassium sparing, this increases K+ levels and makes it harder for digoxin to bind = decreased effiacy

spironolactone

63
New cards

which digoxin DDI causes decrease in potassium, increasing digoxin toxicity due to less compition at Na/K pump

loop and thiazide diuretics

64
New cards

which digoxin DDI adds to digoxin’s vagal slowing of SA and AV nodal conduction, leading to the additive effect of severe bradycardia and complete AV block

b-blockers and nonDHP CCBs

65
New cards

which digoxin DDI binds to digoxin and prevents absorption, leading to loss of therapeutic effects

cholestyramine, antacids, kaolin

66
New cards

which digoxin DDI induces pgp, pumping digoxin back out before it is absorbed

Rifampin and St. John's Wort

67
New cards

________ works past beta-blockade but accumulates in renal impairment

Milrinone